Crispr Therapeutics Ag (CRSP)

Total Liabilities

$904.22M

Quarterly · Period ending: · USD

CRSP logo

CRSP Total Liabilities

Latest reported$904.22M
CRSP Quarterly Total Liabilities ($188.55M → $904.22M)
High-resolution chart · PNG

CRSP total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Total Liabilities — Quarterly (USD)
Period endingTotal Liabilities (USD)
904,219,000
911,264,000
343,430,000
329,326,000
318,586,000
336,942,000
309,954,000
316,472,000
358,904,000
355,081,000
346,768,000
359,036,000
380,986,000
389,468,000
367,578,000
399,402,000
372,532,000
361,259,000
352,417,000
308,802,000
295,724,000
152,412,000
163,732,000
141,717,000
135,861,999
121,203,000
127,327,000
128,712,000
126,562,000
118,063,000
96,821,000
101,589,000
87,976,000
84,117,000
83,514,000
103,361,000
107,172,000
107,171,000
112,116,000
341,185,000
157,718,000
75,835,000
188,547,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.